Kevin Laliberte

Overview

Kevin Laliberte received $1M in total compensation, including $338K in salary, at Dova Pharmaceuticals in 2018.

Source: SEC filing on March 15, 2019.

Related executives

We found five more executives who work or worked at Dova Pharmaceuticals.

Mark Hahn

Dova Pharmaceuticals

Chief Financial Officer

David Zaccardelli

Dova Pharmaceuticals

Chief Executive Officer

Alex Sapir

Dova Pharmaceuticals

Chief Executive Officer

Lee Allen

Dova Pharmaceuticals

Chief Medical Officer

Douglas Blankenship

Dova Pharmaceuticals

Chief Financial Officer

News

You may also like